Latest Financial Health News

Page 50 of 68
Bendigo and Adelaide Bank reported a slight dip in its Common Equity Tier 1 ratio to 10.83% for the March 2025 quarter, reflecting dividend payments and increased residential lending. Despite this, the bank sustained robust liquidity and funding metrics well above regulatory minimums.
Victor Sage
Victor Sage
23 May 2025
SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.
Sophie Babbage
Sophie Babbage
22 May 2025
RPM Automotive Group has launched a fully operational tyre recycling plant, boosting its earnings potential while reporting steady revenue and improved profitability for the nine months FYTD.
Victor Sage
Victor Sage
22 May 2025
AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.
Ada Torres
Ada Torres
22 May 2025
Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.
Ada Torres
Ada Torres
21 May 2025
Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.
Sophie Babbage
Sophie Babbage
21 May 2025
James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.
Victor Sage
Victor Sage
21 May 2025
Janus Electric Holdings Limited will have its trading suspension lifted and resume quotation on the ASX from 21 May 2025 after meeting key listing requirements.
Victor Sage
Victor Sage
20 May 2025
Monash IVF Group has lowered its full-year profit guidance for FY2025 to $27.5 million, citing weaker market conditions and ongoing impacts from a recent operational incident in Brisbane. The company remains cautious as it monitors patient trends and legal costs.
Ada Torres
Ada Torres
20 May 2025
Mount Burgess Mining NL has had its trading suspension lifted following a court ruling validating a recent cleansing notice, allowing shares to re-enter the market from 20 May 2025.
Maxwell Dee
Maxwell Dee
20 May 2025
OFX Group Limited has requested a trading halt following significant price and volume spikes in its securities, ahead of its scheduled full year results announcement for FY25.
Claire Turing
Claire Turing
19 May 2025
Raptis Group Limited has had its trading suspension lifted following the announcement of a placement and a pro-rata non-renounceable entitlement offer, signaling a fresh chapter for the company on the ASX.
Claire Turing
Claire Turing
19 May 2025